About: Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована в травні 1996 (uk) article scientifique publié en 1996 (fr) im Mai 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1996 (ast) scientific article published on 01 May 1996 (en)
publication date	wds:Q71338481-16A98251-D706-4885-AB99-9D24BF17F4B8
publication date	1996-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71338481-CD055C65-7D39-41D3-A4B2-5F879EBCDAD0
language of work or name	English
author name string	wds:Q71338481-114CD22C-991D-48AD-9187-4796335D80DE wds:Q71338481-3EA44552-3DE5-4881-8BC7-978C421B9392 wds:Q71338481-406A7D79-FCC7-47E2-AE31-A75CEF181FEE wds:Q71338481-61AFB039-AEB3-4520-AF0E-EB315C324D59 wds:Q71338481-9E179680-34E5-4488-A895-C00D0ABFF9BE wds:Q71338481-A92B5163-9258-4E11-8E32-5FD5AA9E4A1A wds:Q71338481-C99285DE-44C5-40C6-B5AD-18791F06C02C
author name string	N Konietzko R Pauwels L Allegra P Petitpretz J Hosie P Leophonte J N Guyen
rdfs:label	Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study (en) Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study (nl)
skos:prefLabel	Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study (en) Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study (nl)
name	Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study (en) Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study (nl)
title	wds:Q71338481-4C8A13CE-4E1F-4DA4-9ABF-65E9EB54F7E1
title	Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study (en)
page(s)	wds:Q71338481-BFDB3046-1995-4A53-9EC7-E5A08BD0BBF3
page(s)	93-104
instance of	wds:Q71338481-FEFA71E3-9F58-4F4B-AF85-23FC20CD07C3
instance of	scholarly article
main subject	wds:Q71338481-BE172A38-05F7-485F-951F-F0DFC6212615
main subject	chronic obstructive pulmonary disease
PubMed ID	wds:Q71338481-7748AEC6-92C2-4227-9578-7DA62D8DAE5B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8737129
PubMed ID	8737129
published in	wds:Q71338481-03647EF2-7F15-41D1-96C1-F3E3EBA9E939
published in	Journal of Antimicrobial Chemotherapy
volume	wds:Q71338481-E504A805-B4F0-44B1-A56E-161E5BD5D7DB
volume	37 Suppl A
number of pages	wds:Q71338481-437388C4-3F12-4448-BAAE-138DCF62DDAF
number of pages	12 (xsd:decimal)
DOI	wds:Q71338481-DFBF58D6-5D74-46BD-8F2B-0B5F48AE7B5B
DOI	http://dx.doi.org/10.1093/JAC/37.SUPPL_A.93
DOI	10.1093/JAC/37.SUPPL_A.93
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71338481
is cites work of	Antibiotics for exacerbations of chronic obstructive pulmonary disease Comparative antistreptococcal activity of two newer fluoroquinolones, levofloxacin and sparfloxacin. The new fluoroquinolones: A critical review Antibiotics for exacerbations of chronic obstructive pulmonary disease Antibiotics for exacerbations of chronic obstructive pulmonary disease Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review Sparfloxacin In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis. Potential interactions of the extended-spectrum fluoroquinolones with the CNS. Fluoroquinolones for the treatment of outpatient community-acquired pneumonia Comparative in vitro assessment of sparfloxacin activity and spectrum using results from over 14,000 pathogens isolated at 190 medical centers in the USA. SPAR Study Group. Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis New Fluoroquinolones: Real and Potential Roles Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis. Antibiotics for exacerbations of chronic obstructive pulmonary disease Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections Acute exacerbations of chronic bronchitis: what role for the new fluoroquinolones? The next generation: fluoroquinolones in the management of acute lower respiratory infection in adults Effects of food on the pharmacokinetics of sparfloxacin A review of worldwide experience with sparfloxacin in the treatment of community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis
is cites work of	wds:Q24235050-4B8D4AAA-F923-4646-8B0D-8FE868A2FA5A wds:Q34958317-1341A8E1-7D96-42E8-9FEB-7B034C1265B2 wds:Q55983237-9DD030F3-6F82-4CD6-8C1C-59DAF6745CFC wds:Q54137490-C877FA08-7AE9-472D-AD9F-284BD3B7473F wds:Q58102160-D845B8D5-1F2D-4979-8835-4471E18B6CB8 wds:Q32090920-649F5DE5-5AB9-43CA-81E3-F81C03CD66E5 wds:Q73235243-F7663009-3B36-45ED-92E5-7631B17584FD wds:Q24246286-8F108FC0-E099-4857-AEB0-126AF5A01024 wds:Q28307380-B0F4D7A2-1C25-4240-9E02-68CF65801631 wds:Q24202248-8D11F63C-E123-4894-A0DE-6C8550AD0037 wds:Q54152283-9805686A-390C-45AC-9370-3C8ADE20A48E wds:Q33801878-AD46F781-16F0-40EA-A910-E6BB315724F8 wds:Q33975684-CA00825C-D44D-449F-AD40-B44E3E54ADF3 wds:Q37880142-0F0EEBEB-257D-46A2-BC8B-345778AA05E3 wds:Q78107386-C2FDAFFE-E37A-4D4F-88CF-94B3B3D49B23 wds:Q33676506-56E51E20-6122-4E27-9AFA-8DC9FE9D02E5 wds:Q35649595-F49829A6-8D4B-476A-96E9-1B3C258BDEBF wds:Q47127548-6EF67626-CC38-40E7-9597-DD537F80E4E7 wds:Q54152289-4584466D-DED1-4FBD-85BC-FEFDC15965D9 wds:Q33717059-11AB30ED-4594-4E61-BC31-B6D39515A534

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software